Treatment of myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review for a National Institutes of health pathways to prevention workshop

Annals of Internal Medicine

Volumn 162, Issue 12, 2015, Pages 841-850

  Beth Smith, M E ^a   Haney, Elizabeth ^a   McDonagh, Marian ^a   Pappas, Miranda ^a   Daeges, Monica ^a   Wasson, Ngoc ^a   Fu, Rongwei ^a   Nelson, Heidi D ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCLYDINE; CARNITINE; FLUOXETINE; GALANTAMINE; GROWTH FACTOR; HYDROCORTISONE; IMMUNOGLOBULIN G; MELATONIN; METHISOPRINOL; PLACEBO; POLLEN EXTRACT; RINTATOLIMOD; UNCLASSIFIED DRUG; VALGANCICLOVIR; ANTIVIRUS AGENT; IMMUNOLOGIC FACTOR; POLY(I).POLY(C12,U); POLYINOSINIC POLYCYTIDYLIC ACID; POLYURIDYLIC ACID;

ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; CHILL; CHRONIC FATIGUE SYNDROME; COUNSELING; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FLU LIKE SYNDROME; HOMEOPATHY; HUMAN; KINESIOTHERAPY; NATIONAL HEALTH ORGANIZATION; PHOTOTHERAPY; POLLEN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; WORKSHOP; ADULT; COGNITIVE THERAPY; ENCEPHALOMYELITIS; FATIGUE SYNDROME, CHRONIC; META ANALYSIS; MYALGIA;

ADULT; ANTIVIRAL AGENTS; COGNITIVE THERAPY; COMPLEMENTARY THERAPIES; COUNSELING; ENCEPHALOMYELITIS; EXERCISE THERAPY; FATIGUE SYNDROME, CHRONIC; HUMANS; IMMUNOLOGIC FACTORS; MYALGIA; POLY I-C; POLY U; QUALITY OF LIFE;

EID: 84932135234     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-0114     Document Type: Review

References (73)

1. Carruthers BM, Jain AK, de Meirleir KL, Peterson DL, Klimas NG, Lerner A, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr. 2003;11:7-115.
2. Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270:327-38. doi:10.1111/j.1365-2796.2011.02428.x
3. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953-9.
4. Carruthers BM, van de Sande MI, De Meirleir K, Klimas N, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis-Adult & paediatric: international consensus primer for medical practitioners. 2012. Accessed at http://sacfs.asn.au/download/me-international-consensus-primer-for-medical-practitioners.pdf on 11 February 2015.
5. Davenport TE, Stevens SR, VanNess MJ, Snell CR, Little T. Conceptual model for physical therapist management of chronic fatigue syndrome/myalgic encephalomyelitis. Phys Ther. 2010;90:602-14. doi:10.2522/ptj.20090047
6. Jason LA, Brown A, Evans M, Sunnquist M, Newton JL. Contrasting chronic fatigue syndrome versus myalgic encephalomyelitis/ chronic fatigue syndrome. Fatigue. 2013;1:168-183.
7. Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: National Academies Pr; 2015.
8. Jason LA, Roesner N, Porter N, Parenti B, Mortensen J, Till L. Provision of social support to individuals with chronic fatigue syndrome. J Clin Psychol. 2010;66:249-58. doi:10 .1002/jclp.20648
9. Dowsett E, Goudsmit E, Macintyre A, Shepherd C. London Criteria for myalgic encephalomyelitis. In: Report from The National Task Force on Chronic Fatigue Syndrome (CFS), Post Viral Fatigue Syndrome (PVFS), Myalgic Encephalomyelitis (ME). Westcare. 1994. 96-98. Accessed at www.actionforme.org.uk/Resources/Action%20for %20ME/Documents/get-informed/national%20task%20force.pdf on 26 March 2015.
10. Komaroff AL, Cho TA. Role of infection and neurologic dysfunction in chronic fatigue syndrome. Semin Neurol. 2011;31:325-37. doi:http://dx.doi.org/10.1055/s-0031-1287654
11. Morris G, Maes M. A neuro-immune model of Myalgic Encephalomyelitis/ Chronic fatigue syndrome. Metab Brain Dis. 2013;28:523-40 doi:10.1007/s11011-012-9324-8
12. Reyes M, Nisenbaum R, Hoaglin DC, Unger ER, Emmons C, Randall B, et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med. 2003;163:1530-6.
13. Jason LA, Brown A, Clyne E, Bartgis L, Evans M, Brown M. Contrasting case definitions for chronic fatigue syndrome, Myalgic Encephalomyelitis/ chronic fatigue syndrome and myalgic encephalomyelitis. Eval Health Prof. 2012;35:280-304. doi: 10.1177/0163278711424281
14. Reeves WC, Jones JF, Maloney E, Heim C, Hoaglin DC, Boneva RS, et al. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metr. 2007;5:5.
15. Center for Drug Evaluation and Research. The voice of the patient: a series of reports from the U.S. Food and Drug Administration's (FDA's) Patient-Focused Drug Development Initiative. Accessed at www.fda.gov/downloads/ForIndustry/UserFees/Prescription DrugUserFee/UCM368806.pdf on 11 Februrary 2015.
16. Smith M, Nelson H, Haney E, Pappas M, Daeges M, Wasson N, et al. Diagnosis and treatment of myalgic encephalomyelitis/chronic fatigue syndrome. Evidence Report/Technology Assessment No. 219. (Prepared by the Pacific Northwest Evidence-based Practice Center under contract 290-2012-00014-I.) AHRQ Publication No. 15-E001-EF. Rockville, MD: Agency for Healthcare Research and Quality; December 2014. Accessed at http://effectivehealthcare .ahrq.gov/ehc/products/586/2004/chronic-fatigue-report-141209.pdf on 26 March 2015.
17. Smith ME, Nelson N, Haney E, McDonagh M, Pappas M, Daeges M, et al. Diagnosis and treatment of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS). Accessed at www.crd.york.ac.uk/PROSPERO/display-record.asp?ID=CRD42014009779 on 11 February 2015.
18. Owens D, Lohr KN, Atkins D, Treadwell J, Reston J, Bass E, et al. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
19. Hardy RJ, Thompson SG. A likelihood approach to meta-Analysis with random effects. Stat Med. 1996;15:619-29.
20. Peterson PK, Shepard J, Macres M, Schenck C, Crosson J, Rechtman D, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med. 1990;89:554-60.
21. Strayer DR, Carter WA, Brodsky I, Cheney P, Peterson D, Salvato P, et al. A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome. Clin Infect Dis. 1994;18 Suppl 1:S88-95.
22. McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA. 1998;280:1061-6.
23. Wearden AJ, Morriss RK, Mullis R, Strickland PL, Pearson DJ, Appleby L, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry. 1998;172:485-90.
24. Blockmans D, Persoons P, Van Houdenhove B, Lejeune M, Bobbaers H. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized placebo-controlled double-blind crossover study. Am J Med. 2003;114:736-41.
25. Diaz-Mitoma F, Turgonyi E, Kumar A, Lim W, Larocque L, Hyde BM. Clinical improvement in chronic fatigue syndrome is associated with enhanced natural killer cell-mediated cytotoxicity: the results of a pilot study with Isoprinosine. J Chronic Fatigue Syndr. 2003;11:71-93.
26. Blacker CV, Greenwood DT, Wesnes KA, Wilson R, Woodward C, Howe I, et al. Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial. JAMA. 2004;292: 1195-204.
27. Strayer DR, Carter WA, Stouch BC, Stevens SR, Bateman L, Cimoch PJ, et al; Chronic Fatigue Syndrome AMP-516 Study Group. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS One. 2012;7:e31334. doi:10.1371/journal.pone.0031334
28. Montoya JG, Kogelnik AM, Bhangoo M, Lunn MR, Flamand L, Merrihew LE, et al. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. J Med Virol. 2013;85:2101-9. doi: 10.1002/jmv.23713
29. Hobday RA, Thomas S, O'Donovan A, Murphy M, Pinching AJ. Dietary intervention in chronic fatigue syndrome. J Hum Nutr Diet. 2008;21:141-9. doi:10.1111/j.1365-277X.2008 .00857.x
30. Öckerman PA. Antioxidant treatment of chronic fatigue syndrome. Clin Pract Alternat Med. 2000;1:88-91.
31. The GK, Bleijenberg G, van der Meer JW. The effect of acclydine in chronic fatigue syndrome: a randomized controlled trial. PLoS Clin Trials. 2007;2:e19.
32. Vermeulen RC, Scholte HR. Exploratory open label, randomized study of acetyl-And propionylcarnitine in chronic fatigue syndrome. Psychosom Med. 2004;66:276-82.
33. Walach H, Bosch H, Lewith G, Naumann J, Schwarzer B, Falk S, et al. Effectiveness of distant healing for patients with chronic fatigue syndrome: a randomised controlled partially blinded trial (EUHEALS). Psychother Psychosom. 2008;77:158-66. doi:10 .1159/000116609
34. Weatherley-Jones E, Nicholl JP, Thomas KJ, Parry GJ, McKendrick MW, Green ST, et al. A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome. J Psychosom Res. 2004;56:189-97.
35. Williams G, Waterhouse J, Mugarza J, Minors D, Hayden K. Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy. Eur J Clin Invest. 2002;32:831-7.
36. Bazelmans E, Prins JB, Lulofs R, van der Meer JW, Bleijenberg G; Netherlands Fatigue Research Group Nijmegen. Cognitive behaviour group therapy for chronic fatigue syndrome: a non-randomised waiting list controlled study. Psychother Psychosom. 2005;74:218-24.
37. Burgess M, Andiappan M, Chalder T. Cognitive behaviour therapy for chronic fatigue syndrome in adults: face to face versus telephone treatment: a randomized controlled trial. Behav Cogn Psychother. 2012;40:175-91. doi:10.1017/S1352465811000543
38. Deale A, Chalder T, Marks I, Wessely S. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. Am J Psychiatry. 1997;154:408-14.
39. Goudsmit EM, Ho-Yen DO, Dancey CP. Learning to cope with chronic illness. Efficacy of a multi-component treatment for people with chronic fatigue syndrome. Patient Educ Couns. 2009;77:231-6. doi:10.1016/j.pec.2009.05.015
40. Jason LA, Torres-Harding S, Friedberg F, Corradi K, Njoku MG, Donalek J, et al. Non-pharmacologic interventions for CFS: a randomized trial. J Clin Psychol Med Settings. 2007;14:275-96.
41. Knoop H, van der Meer JW, Bleijenberg G. Guided selfinstructions for people with chronic fatigue syndrome: randomised controlled trial. Br J Psychiatry. 2008;193:340-1. doi:10.1192/bjp.bp.108.051292
42. Lopez C, Antoni M, Penedo F, Weiss D, Cruess S, Segotas MC, et al. A pilot study of cognitive behavioral stress management effects on stress, quality of life, and symptoms in persons with chronic fatigue syndrome. J Psychosom Res. 2011;70:328-34. doi:10.1016/j.jpsychores.2010.11.010
43. O'Dowd H, Gladwell P, Rogers CA, Hollinghurst S, Gregory A. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. Health Technol Assess. 2006;10:iii-iv, ix-x, 1-121.
44. Sharpe M, Hawton K, Simkin S, Surawy C, Hackmann A, Klimes I, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial. BMJ. 1996;312:22-6.
45. Taylor RR. Quality of life and symptom severity for individuals with chronic fatigue syndrome: findings from a randomized clinical trial. Am J Occup Ther. 2004;58:35-43.
46. Tummers M, Knoop H, van Dam A, Bleijenberg G. Implementing a minimal intervention for chronic fatigue syndrome in a mental health centre: a randomized controlled trial. Psychol Med. 2012;42: 2205-15. doi:10.1017/S0033291712000232
47. Wearden AJ, Dowrick C, Chew-Graham C, Bentall RP, Morriss RK, Peters S, et al; Fatigue Intervention by Nurses Evaluation (FINE) trial writing group and the FINE trial group. Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial. BMJ. 2010;340:c1777. doi:10.1136/bmj.c1777
48. White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, De-Cesare JC, et al; PACE trial management group. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. 2011;377:823-36. doi:10.1016/S0140-6736(11)60096-2
49. Chan JS, Ho RT, Wang CW, Yuen LP, Sham JST, Chan CL. Effects of qigong exercise on fatigue, anxiety, and depressive symptoms of patients with chronic fatigue syndrome-like illness: a randomized controlled trial. Evidence based Complement Alternat Med. 2013; 2013:485341.
50. Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ. 1997; 314:1647-52.
51. Ho RT, Chan JS, Wang CW, Lau BW, So KF, Yuen LP, et al. A randomized controlled trial of qigong exercise on fatigue symptoms, functioning, and telomerase activity in persons with chronic fatigue or chronic fatigue syndrome. Ann Behav Med. 2012;44:160-70. doi:10.1007/s12160-012-9381-6
52. Moss-Morris R, Sharon C, Tobin R, Baldi JC. A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change. J Health Psychol. 2005;10:245-59.
53. Nuńez M, Fernańdez-Sola J, Nunez E, Fernańdez-Huerta JM, Godas-Sieso T, Gomez-Gil E. Health-related quality of life in patients with chronic fatigue syndrome: group cognitive behavioural therapy and graded exercise versus usual treatment. A randomised controlled trial with 1 year of follow-up. Clin Rheumatol. 2011;30:381-9. doi:10.1007/s10067-010-1677-y
54. Sutcliffe K, Gray J, Tan MP, Pairman J, Wilton K, Parry SW, et al. Home orthostatic training in chronic fatigue syndrome-A randomized, placebo-controlled feasibility study. Eur J Clin Invest. 2010;40: 18-24. doi:10.1111/j.1365-2362.2009.02225.x
55. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988;108:387-9.
56. Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, et al. A report-chronic fatigue syndrome: guidelines for research. J R Soc Med. 1991;84:118-21.
57. Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM, et al. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med. 1988;319:1692-8.
58. Fluge Ø, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A doubleblind and placebo-controlled study. PLoS One. 2011;6:e26358. doi:10.1371/journal.pone.0026358
59. Deale A, Husain K, Chalder T, Wessely S. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry. 2001; 158:2038-42.
60. Hlavaty LE, Brown MM, Jason LA. The effect of homework compliance on treatment outcomes for participants with myalgic encephalomyelitis/ chronic fatigue syndrome. Rehabil Psychol. 2011;56: 212-8. doi:10.1037/a0024118
61. Jason L, Benton M, Torres-Harding S, Muldowney K. The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFS. Patient Educ Couns. 2009;77:237-41. doi:10.1016/j.pec.2009.02.015
62. Tummers M, Knoop H, Bleijenberg G. Effectiveness of stepped care for chronic fatigue syndrome: a randomized noninferiority trial. J Consult Clin Psychol. 2010;78:724-31. doi:10 .1037/a0020052
63. Wearden AJ, Dunn G, Dowrick C, Morriss RK. Depressive symptoms and pragmatic rehabilitation for chronic fatigue syndrome. Br J Psychiatry. 2012;201:227-32. doi:10.1192/bjp.bp .111.107474
64. Wearden AJ, Emsley R. Mediators of the effects on fatigue of pragmatic rehabilitation for chronic fatigue syndrome. J Consult Clin Psychol. 2013;81:831-8. doi:10.1037/a0033561
65. Dougall D, Johnson A, Goldsmith K, Sharpe M, Angus B, Chalder T, et al. Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome. J Psychosom Res. 2014;77:20-6. doi:10.1016/j .jpsychores.2014.04.002
66. Alraek T, Lee MS, Choi TY, Cao H, Liu J. Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review. BMC Complement Altern Med. 2011;11:87. doi:10.1186/1472-6882-11-87
67. Chambers D, Bagnall AM, Hempel S, Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J R Soc Med. 2006;99:506-20.
68. Edmonds M, McGuire H, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. 2004:CD003200.
69. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramírez G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA. 2001;286: 1360-8.
70. Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. 2015;2:CD003200. doi:10.1002/14651858 .CD003200.pub3
71. Haney E, Smith ME, McDonagh M, Pappas M, Daeges M, Wasson N, et al. Diagnostic methods for myalgic encephalomyelitis/ chronic fatigue syndrome: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:834-40. doi:10.7326/M15-0443
72. Ganiats TG. Redefining the chronic fatigue syndrome. Ann Intern Med. 2015;162:653-4. doi:10.7326/M15-03577
73. Tummers M, Knoop H, van Dam A, Bleijenberg G. Moderators of the treatment response to guided self-instruction for chronic fatigue syndrome. J Psychosom Res. 2013;74:373-7. doi:10.1016/j.jpsychores.2013.01.007